← Alle mensen

CL

Chih-Jian Lih

2 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab bij eerstelijns CLL: iLLUMINATE fase III
The Lancet. Oncology · 2019-01
Lenalidomide versus investigator's choice bij recidief/refractair indolent lymfoom: fase II/III-studie
Clinical cancer research : an official journal of the American Association for Cancer Research · 1 augustus 2017